Cited by 480Metabolism and Genetic DisordersCholesterol and Lipid MetabolismGenetic and rare skin diseases.

The Smith-Lemli-Opitz syndrome

Open access
Kelley, Richard I, Hennekam, Raoul C M·2000·Journal of Medical Genetics

Abstract

The Smith-Lemli-Opitz syndrome (SLOS) is one of the archetypical multiple congenital malformation syndromes. The recent discovery of the biochemical cause of SLOS and the subsequent redefinition of SLOS as an inborn error of cholesterol metabolism have led to important new treatment possibilities for affected patients. Moreover, the recent recognition of the important role of cholesterol in vertebrate embryogenesis, especially with regard to the hedgehog embryonic signalling pathway and its effects on the expression of homeobox genes, has provided an explanation for the abnormal morphogenesis in the syndrome. The well known role of cholesterol in the formation of steroid hormones has also provided a possible explanation for the abnormal behavioural characteristics of SLOS.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/jmg.37.5.321

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The occipital frontal head circumference is proportionately the smallest measurement at birth and is 2 standard deviations below the typical population.

    “the occipital frontal head circumference (OFC) is proportionately the smallest measurement at birth and is 2 standard deviations (SD) below the typical population [50, 51].”

    From Sterol and lipid analyses identifies hypolipidemia and apolipoprotein disorders in autism associated with adaptive functioning deficits (2021) · cites this paper as [50]

    The Natural history section says head circumference is proportionately the smallest measurement at birth. It does not give a birth head-circumference value of exactly 2 SD below normal: it gives a range of −1 to −5 SD for most measurements in classical SLOS and a separate adult range. (LLM, conf=0.90)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 162

  1. Smith DW, Lemli L, Opitz JM. A newly recognized syndrome of multiple congenital anomalies. J Pediatr 1964;64:210-17.
  2. Fine RN, Gwinn JL, Young EF. Smith-Lemli-Opitz syndrome. Radiologic and postmortem findings. Am J Dis Child 1968;115:483-8.
  3. Finley SC, Finley WH, Monsky DB. Cataracts in a girl with features of the Smith-Lemli-Opitz syndrome. J Pediatr 1969;75:706-7.
  4. Kaufman R, Alcala H, Sly H, Hartmann A. Brain malformations in Smith-Lemli-Opitz syndrome. Am J Hum Genet 1974;26:47A.
  5. Cotlier E, Rice P. Cataracts in the Smith-Lemli-Opitz syndrome. Am J Ophthalmol 1971;72:955-9.
  6. Robinson CD, Perry LW, Barlee A, Mella GW. Smith- Lemli-Opitz syndrome with cardiovascular abnormality. Pediatrics 1971;47:844-7.
  7. Dallaire L. Syndrome of retardation with urogenital and skeletal anomalies (Smith-Lemli-Opitz syndrome): clinical features and mode of inheritance. J Med Genet 1969;6:113- 20.
  8. Cherstvoy ED, Lazjuk GI, Lurie IW, Nedzved MK, Usoev SS. The pathological anatomy of the Smith-Lemli-Opitz syndrome. Clin Genet 1975;7:382-7.
  9. Johnson VP. Smith-Lemli-Opitz syndrome: review and report of two aVected siblings. Z Kinderheilkd 1975;119: 221-34.
  10. Gold JD, PfaVenbach DD. Ocular abnormalities in the Smith-Lemli-Opitz syndrome. J Pediatr Ophthalmol 1975; 12:228-34.
  11. Curry CJ, Carey JC, Holland JS, et al. Smith-Lemli-Opitz syndrome-type II: multiple congenital anomalies with male pseudohermaphroditism and frequent early lethality. Am J Med Genet 1987;26:45-57.
  12. Donnai D, Young ID, Owen WG, Clark SA, Miller PF, Knox WF. The lethal multiple congenital anomaly syndrome of polydactyly, sex reversal, renal hypoplasia, and unilobular lungs. J Med Genet 1986;23:64-71.
  13. Scarbrough PR, Huddleston K, Finley SC. An additional case of Smith-Lemli-Opitz syndrome in a 46,XY infant with female external genitalia. J Med Genet 1986;23: 174-5.
  14. Bialer MG, Penchaszadeh VB, Kahn E, Libes R, Krigsman G, Lesser ML. Female external genitalia and mullerian duct derivatives in a 46,XY infant with the Smith-Lemli- Opitz syndrome. Am J Med Genet 1987;28:723-31.
  15. Belmont JW, Hawkins E, Hejtmancik JF, Greenberg F. Two cases of severe lethal Smith-Lemli-Opitz syndrome. Am J Med Genet 1987;26:65-7.
  16. McKeever PA, Young ID. Smith-Lemli-Opitz syndrome II: a disorder of the fetal adrenals? J Med Genet 1990;27: 465-6.
  17. Chasalow FI, Blethen SL, Taysi K. Possible abnormalities of steroid secretion in children with Smith-Lemli-Opitz syndrome and their parents. Steroids 1985;46:827-43.
  18. Natowicz MR, Evans JE. Abnormal bile acids in the Smith- Lemli-Opitz syndrome. Am J Med Genet 1994;50:364-7.
  19. Kandutsch AA, Russell AE. Preputial gland tumor sterols. III. A metabolic pathway from lanosterol to cholesterol. J Biol Chem 1960;235:2256-61.
  20. Tint GS, Irons M, Elias ER, et al. Defective cholesterol bio- synthesis associated with the Smith-Lemli-Opitz syn- drome. N Engl J Med 1994;330:107-13.
  21. CunniV C, Kratz LE, Moser A, Natowicz MR, Kelley RI. Clinical and biochemical spectrum of patients with RSH/Smith-Lemli-Opitz syndrome and abnormal choles- terol metabolism. Am J Med Genet 1997;68:263-9.
  22. Moebius FF, Fitzky BU, Lee JN, Paik YK, Glossmann H. Molecular cloning and expression of the human delta7- sterol reductase. Proc Natl Acad Sci USA 1998;95:1899- 902.
  23. Ryan AK, Bartlett K, Clayton P, et al. Smith-Lemli-Opitz syndrome: a variable clinical and biochemical phenotype. J Med Genet 1998;35:558-65.
  24. Bene M, Duca D, Ioan D, Maximilian C. The Smith-Lemli- Opitz syndrome: ten new observations. Acta Med Auxol 1980;12:5-15.
  25. Krajewska-Walasek M, Gradowska W, Ryzko J, et al. Further delineation of the classical Smith-Lemli-Opitz syndrome phenotype at diVerent patient ages: clinical and biochemi- cal studies. Clin Dysmorphol 1999;8:29-40.
  26. Cruveiller J, Msika S, Lafourcade J. Nanisme de Smith- Lemli-Opitz: a propos de quatre observations. Revue de la littérature. Sem Hop (France) 1977;53:843-51.
  27. Le Merrer M, Briard ML, Girard S, Mulliez N, Moraine C, Inibert MC. Lethal acrodysgenital dwarfism: a severe lethal condition resembling Smith-Lemli-Opitz syndrome. J Med Genet 1988;25:88-95.
  28. Meinecke P, Blunck W, Rodewald A. Smith-Lemli-Opitz syndrome. Am J Med Genet 1987;28:735-9.
  29. Anderson AJ, Stephan MJ, Walker WO, Kelley RI. Variant RSH/Smith-Lemli-Opitz syndrome with atypical sterol metabolism. Am J Med Genet 1998;78:413-18.
  30. Lowry RB, Yong SL. Borderline normal intelligence in the Smith-Lemli-Opitz (RSH) syndrome. Am J Med Genet 1980;5:137-43.
  31. Kelley RI. Editorial. A new face for an old syndrome. Am J Med Genet 1997;68:251-6.
  32. Tsukahara M, Fujisawa K, Yamamoto K, et al. Smith-Lemli- Opitz syndrome in Japan. Am J Med Genet 1998;75:118- 19.
  33. Hanissian AS, Summitt RL. Smith-Lemli-Opitz syndrome in a negro child. J Pediatr 1969;74:303-5.
  34. Verma IC, Ghai OP. Smith-Lemli-Opitz syndrome in an Indian child. Indian J Pediatr 1971;8:221-2.
  35. Tomaraei SN, Sarkar B, Bansali A, Marwaha RK. Smith-Lemli-Opitz syndrome. Indian J Pediatr 1993;60: 143-5.
  36. Iros JE, Sanchez GH. Smith-Lemli-Opitz syndrome. Arch Arg Pediatr 1970;68:23-8.
  37. Nowaczyk MJ, Whelan DT, Hill RE. Smith-Lemli-Opitz syndrome: phenotypic extreme with minimal clinical findings. Am J Med Genet 1998;78:419-23.
  38. Gold JD, PfaVenbach DD. Ocular abnormalities in the Smith-Lemli-Opitz syndrome. J Pediatr Ophthalmol 1975; 12:228-34.
  39. Harbin RL, Katz JI, Frias JL, Rabinowicz IM, Kaufman HE. Sclerocornea associated with the Smith-Lemli-Opitz syn- drome. Am J Ophthalmol 1977;84:72-3.
  40. Fierro M, Martinez AJ, Harbison JW, Hay SH. Smith- Lemli-Opitz syndrome: neuropathological and ophthalmo- logical observations. Dev Med Child Neurol 1977;19:57-62.
  41. Kretzer FL, Hittner HM, Mehta RS. Ocular manifestations of the Smith-Lemli-Opitz syndrome. Arch Ophthalmol 1981;99:2000-6.
  42. Bardelli AM, Lasorella G, Barberi L, Vanni M. Ocular manifestations in Kniest syndrome, Smith-Lemli-Opitz syndrome, Hallermann-StreiV-Francois syndrome, Rubinstein-Taybi syndrome and median cleft face syn- drome. Ophthal Paediatr Genet 1985;6:343-7.
  43. Fagerstrom CL, Chitayat D, Kalousek DK, Rootman J, Tay- lor GP, Hall JG. Unique eye anomaly and features of Smith-Lemli-Opitz (SLO) syndrome in de novo t(1; 2)(p22;q23). Am J Hum Genet Suppl 1987;39:A57.
  44. Pauli RM, Williams MS, Josephson KD, Tint GS. Smith-Lemli-Opitz syndrome: thirty-year follow-up of "S" of "RSH" syndrome. Am J Med Genet 1997;68:260-2.
  45. Freedman RA, Baum JL. Postlenticular membrane associ- ated with Smith-Lemli-Opitz syndrome. Am J Ophthalmol 1979;87:675-7.
  46. Gracia R, Nieto JA, Nistal M, et al. Associación de aniridia con tumor embrionario no renal (gonadoblastoma) en nino con síndrome de Smith-Lemli-Opitz. An Esp Pediatr 1976; 9:19-24.
  47. Kohler HG. Brief clinical report: familial neonatally lethal syndrome of hypoplastic left heart, absent pulmonary loba- tion, polydactyly, and talipes, probably Smith-Lemli-Opitz (RSH) syndrome. Am J Med Genet 1983;14:423-8.
  48. Chakanovskis JE, Sutherland GR. The Smith-Lemli-Opitz syndrome in a profoundly retarded epileptic boy. J Ment Defic 1971;15:153-62.
  49. Rutledge JC, Friedman JM, Harrod MJ, et al. A "new" lethal multiple congenital anomaly syndrome: joint contractures, cerebellar hypoplasia, renal hypoplasia, urogenital anoma- lies, tongue cysts, shortness of limbs, eye abnormalities, defects of the heart, gallbladder agenesis, and ear malformations. Am J Med Genet 1984;19:255-64.
  50. Fried K, Fraser WI. Smith-Lemli-Opitz syndrome in an adult. J Ment Defic Res 1972;16:30-4.
  51. Stewart FJ, Nevin NC, Dornan JC. Prenatal diagnosis of Smith-Lemli-Opitz syndrome. Am J Med Genet 1995;56: 286-7.
  52. Worthington S, Goldblatt J. Smith-Lemli-Opitz syndrome: further delineation of the phenotype. Clin Dysmorphol 1997;6:263-6.
  53. Berry R, Wilson H, Robinson J, et al. Apparent Smith- Lemli-Opitz syndrome and Miller-Dieker syndrome in a family with segregating translocation t(7;17)(q34;p13.1). Am J Med Genet 1989;34:358-65.
  54. Kelley RL, Roessler E, Hennekam RCM, et al. Holoprosen- cephaly in RSH/Smith-Lemli-Opitz syndrome: does abnor- mal cholesterol metabolism aVect the function of Sonic Hedgehog? Am J Med Genet 1996;66:478-84.
  55. de Die-Smulders C, Fryns JP. Smith-Lemli-Opitz syndrome: the changing phenotype with age. Genet Couns 1992;3:77-82.
  56. Joseph DB, Uehling DT, Gilbert E, Laxova R. Genitouri- nary abnormalities associated with the Smith-Lemli-Opitz syndrome. J Urol 1987;137:719-21.
  57. Hyett JA, Clayton PT, Moscoso G, Nicolaides KH. Increased first trimester nuchal translucency as a prenatal manifestation of Smith-Lemli-Opitz syndrome. Am J Med Genet 1995;58:374-6.
  58. Garcia CA, McGarry PA, Voirol M, Duncan C. Neurologi- cal involvement in the Smith-Lemli-Opitz syndrome: clini- cal and neuropathological findings. Dev Med Child Neurol 1973;15:48-55.
  59. Cherstvoy ED, Lazjuk GI, Ostrovskaya TI, et al. The Smith- Lemli-Opitz syndrome. A detailed pathological study as a clue to a etiological heterogeneity. Virchows Arch A Pathol Anat Histopathol 1984;404:413-25.
  60. Marion RW, Alvarez LA, Marans ZS, Lantos G, Chitayat D. Computed tomography of the brain in the Smith-Lemli- Opitz syndrome. J Child Neurol 1987;2:198-200.
  61. Zucker JM, Job JC, Rossier A. A new variety of dystrophic intra-uterine nanism: Smith-Lemli-Opitz syndrome. Ann Pediatr 1967;14:2409-11.
  62. Ness GC, Lopez D, Borrego O, Gilbert-Barness E. Increased expression of low-density lipoprotein receptors in a Smith-Lemli-Opitz infant with elevated bilirubin levels. Am J Med Genet 1997;68:294-9.
  63. Herman TE, Siegel MJ, Lee BC, Dowton SB. Smith-Lemli- Opitz syndrome type II: report of a case with additional radiographic findings. Pediatr Radiol 1993;23:37-40.
  64. Nwokoro NA, Mulvihill JJ. Cholesterol and bile acid replacement therapy in children and adults with Smith- Lemli-Opitz (SLO/RSH) syndrome. Am J Med Genet 1997;68:315-21.
  65. de Jong G, Kirby PA, Muller LM. RSH (Smith-Lemli- Opitz) syndrome: "severe" phenotype with ectrodactyly. Am J Med Genet 1998;75:283-7.
  66. Irons M, Elias ER, Tint GS, et al. Abnormal cholesterol metabolism in the Smith-Lemli-Opitz syndrome: report of clinical and biochemical findings in four patients and treat- ment in one patient. Am J Med Genet 1994;50:347-52.
  67. Rossiter JP, Hofman KJ, Kelley RI. Smith-Lemli-Opitz syndrome: prenatal diagnosis by quantification of choles- terol precursors in amniotic fluid. Am J Med Genet 1995; 56:272-5.
  68. Pankau R, Partsch CJ, Funda J, Sippell WG. Hypothalamic-pituitary-gonadal function in two infants with Smith-Lemli-Opitz syndrome. Am J Med Genet 1992; 43:513-16.
  69. Parnes S, Hunter AG, Jimenez C, Carpenter BF, MacDon- ald I. Apparent Smith-Lemli-Opitz syndrome in a child with a previously undescribed form of mucolipidosis not involving the neurons. Am J Med Genet 1990;35:397-405.
  70. Itokazu N, Ohba K, Sonoda T, Ohdo S. Infantile spasms in monozygotic twins with Smith-Lemli-Opitz syndrome type 1. No to Hattatsu 1992;24:485-90.
  71. Deaton JG, Mendoza LO. Smith-Lemli-Opitz syndrome in a 23-year-old man. Arch Intern Med 1973;132:422-3.
  72. Pinsky L, DiGeorge AM. A familial syndrome of facial and skeletal anomalies associated with genital abnormality in the male and normal genitals in the female. J Pediatr 1965; 66:1049-54.
  73. Kenis H, Hustinx TW. A familial syndrome of mental retar- dation in association with multiple congenital anomalies resembling the syndrome of Smith-Lemli-Opitz. Maand- schr Kindergeneeskd 1967;35:37-48.
  74. Pierquin G, Peeters P, Roels F, et al. Severe Smith-Lemli- Opitz syndrome with prolonged survival and lipid abnor- malities. Am J Med Genet 1995;56:276-80.
  75. Singer LP, Marion RW, Li JK. Limb deficiency in an infant with Smith-Lemli-Opitz syndrome. Am J Med Genet 1989; 32:380-3.
  76. Ruvalcaba RHA, Reichert A, Smith DW. Smith-Lemli- Opitz syndrome. Case report. Arch Dis Child 1968;43:620- 3.
  77. Seller MJ, Russell J, Tint GS. Unusual case of Smith-Lemli- Opitz syndrome "type II". Am J Med Genet 1995;56:265-8.
  78. Nevo S, Benderly A, Levy J, Katznelson MB. Smith-Lemli- Opitz syndrome in an inbred family. Am J Dis Child 1972; 124:431-3.
  79. McGaughran JM, Clayton PT, Mills KA, Rimmer S, Moore L, Donnai D. Prenatal diagnosis of Smith-Lemli-Opitz syndrome. Am J Med Genet 1995;56:269-71.
  80. Le Merrer M. Acrodysgenital dwarfism or Smith-Lemli- Opitz type II syndrome. Clin Genet 1991;40:252.
  81. Retbi JM, Limal JM, Boutignon H, Rosenstein-Retbi J, Dayras JC. Smith-Lemli-Opitz syndrome with male pseudohermaphroditism. A case report with endocrino- logical study. Ann Pediatr 1981;28:55-8.
  82. Wallace M, Zori RT, Alley T, Whidden E, Gray BA, Williams CA. Smith-Lemli-Opitz syndrome in a female with a de novo, balanced translocation involving 7q32: probable disruption of an SLOS gene. Am J Med Genet 1994;50:368-74.
  83. Joseph DB, Uehling DT, Gilbert E, Laxova R. Genitouri- nary abnormalities associated with the Smith-Lemli-Opitz syndrome. J Urol 1987;137:719-21.
  84. Patterson K, Toomey KE, Chandra RS. Hirschsprung disease in a 46,XY phenotypic infant girl with Smith- Lemli-Opitz syndrome. J Pediatr 1983;103:425-7.
  85. Calvani M, Tirasacchi V, Toscano V, Bellussi A, Fortuna C. Early thelarche and hyperprolactinemia in the Smith- Lemli-Opitz syndrome. Minerva Pediatr 1979;31:1721-32.
  86. Patsner B, Mann WJ, Chumas J. Malignant mixed germ cell tumor of the ovary in a young woman with Smith-Lemli- Opitz syndrome. Gynecol Oncol 1989;33:386-8.
  87. Lin AE, Ardinger HH, Ardinger RH Jr, CunniV C, Kelley RI. Cardiovascular malformations in Smith-Lemli-Opitz syndrome. Am J Med Genet 1997;68:270-8.
  88. Akl KF, Khudr GS, De Kaloustian VM, Najjar SS. The Smith-Lemli-Opitz syndrome. Report of a consanguineous Arab infant with bilateral focal renal dysplasia. Clin Pediatr 1977;16:665-8.
  89. Kratz LE, Kelley RI. Prenatal diagnosis of the RSH/Smith- Lemli-Opitz syndrome. Am J Med Genet 1999;82:376-81.
  90. Andersson HC, Frentz J, Martinez JE, Tuck-Muller CM, Bellizaire J. Adrenal insuYciency in Smith-Lemli-Opitz syndrome. Am J Med Genet 1999;82:382-4.
  91. Schechter R, Torfs CP, Bateson TF. The epidemiology of infantile hypertrophic pyloric stenosis. Paediatr Perinat Epi- demiol 1997;11:407-11.
  92. Kim EH, Boutwell WC. Smith-Lemli-Opitz syndrome asso- ciated with Hirschsprung disease, 46,XY female karyotype, and total anomalous pulmonary venous drainage. J Pediatr 1985;106:861.
  93. Zizka J, Maresova J, Kerekes Z, Nozicka Z, Juttnerova V, Balicek P. Intestinal aganglionosis in the Smith-Lemli- Opitz syndrome. Acta Paediatr Scand 1983;72:141-3. 100
  94. Karsten J, Kosztolanyi G. Smith-Lemli-Opitz syndrome in siblings. Acta Paediatr Hung 1992;32:127-34. 101
  95. Porter FD, Wassif CA, Tsokos M, Steiner RD. Impaired intracellular LDL cholesterol metabolism in Smith-Lemli- Opitz syndrome fibroblasts. In press. 102
  96. Lachman MF, Wright Y, Whiteman DA, Herson V, Green- stein RM. Brief clinical report: a 46,XY phenotypic female with Smith-Lemli-Opitz syndrome. Clin Genet 1991;39: 136-41. 103
  97. Degenhardt F, Muhlhaus K. Delayed bone growth as a sonographic sign in the early detection of Smith-Lemli- Opitz syndrome. Ztschr Geburtshilfe Perinat 1988;192:169- 72. 104
  98. Tzouvelekis G, Antoniades K, Batma A, Nanas C. Smith- Lemli-Opitz syndrome in female, monozygotic twins. Clin Genet 1991;40:229-32. 105
  99. Mizushima A, Satoyoshi M. Unusual responses of muscu- lar rigidity and hypothermia to halothane and succinylcholine; a case report of Smith-Lemli-Opitz (SLO) syndrome. Masui 1988;37:1118-23. 106
  100. Petersen WC, Crouch ER Jr. Anesthesia-induced rigidity, unrelated to succinylcholine, associated with Smith-Lemli- Opitz syndrome and malignant hyperthermia. Anesth Analg 1995;80:606-8. 107
  101. Zahle Ostergaard G, Nielsen H, Friis B. Defective monocyte oxidative metabolism in a child with Smith- Lemli-Opitz syndrome. Eur J Pediatr 1992;151:291-4. 109
  102. Opitz JM. RSH/SLO ("Smith-Lemli-Opitz") syndrome: historical, genetic, and developmental considerations. Am J Med Genet 1994;50:344-6. 110
  103. Kunze J. Das Ullrich-Feichtiger-Syndrom. Arch Kinder- heilkd 1969;179:182-94. 112
  104. Hovels O, Mullereisert F. Der "Typhus Rostockiensis" als charakteristisches Kombinationsbild multipler Missbildun- gen (Polydaktylie, Hypospadie, Kryptorchismus, und Mikrognathie). Zeitschr Kinderheilkd 1955;77:454-9. 113
  105. Lowry RB, Miller JR, MacLean JR. Micrognathia, polydactyly, and cleft palate. J Pediatr 1968;72:859-61. 114
  106. Cormier-Daire V, Wolf C, Munnich A, et al. Abnormal cholesterol biosynthesis in the Smith-Lemli-Opitz and the lethal acrodysgenital syndromes. Eur J Pediatr 1996;155: 656-9. 115
  107. Silengo M, Kaufman RL, Kissane J. A 46,XY infant with uterus, dysgenetic gonads and multiple anomalies. Human- genetik 1974;25:65-8. 116
  108. Greenberg F, Gresik MV, Carpenter RJ, Law SW, HoVman LP, Ledbetter DH. The Gardner-Silengo-Wachtel or genito-palato-cardiac syndrome: male pseudohermaphro- ditism with micrognathia, cleft palate, and conotruncal cardiac defect. Am J Med Genet 1987;26:59-64. 117
  109. Verloes A, Ayme S, Gambarelli D, et al. Holoprosencephaly-polydactyly ('pseudotrisomy 13') syndrome: a syndrome with features of hydrolethalus and Smith-Lemli-Opitz syndromes. A collaborative multicentre study. J Med Genet 1991;28:297-303. 118
  110. Hennekam RCM, van Noort G, de la Fuente AA. Familial holoprosencephaly, heart defects, and polydactyly. Am J Med Genet 1991;41:258-62. 119
  111. Verloes A, Gillerot Y, Langhendries JP, Fryns JP, Koulischer L. Variability versus heterogeneity in syndromal hypothalamic hamartoblastoma and related disorders: review and delineation of the cerebro-acro-visceral early lethality (CAVE) multiplex syndrome. Am J Med Genet 1992;43:669-77. 120
  112. Sanderson DM, Fraser FC. Proptosis, Robin association, clenched hands, and multiple abnormalities. J Clin Dysmorphol 1983;1:19-21. 121
  113. Ades LC, Clapton WK, Morphett A, Morris LL, Haan EA. Polydactyly, campomelia, ambiguous genitalia, cystic kidneys, and cerebral malformation in a fetus of consan- guineous parents: a new multiple malformation syndrome or a severe form of oral-facial-digital syndrome type IV? Am J Med Genet 1984;49:211-17. 122
  114. Casamassima AC, Mamunes P, Gladstone IM, Solomon S, Moncure C. A new syndrome with features of the Smith-Lemli-Opitz and Meckel-Gruber syndromes in a sibship with cerebellar defects. Am J Med Genet 1987;26: 321-36. 123
  115. Fraser FC, Jequier S, Chen MF. Chondrodysplasia, situs inversus totalis, cleft epiglottis and larynx, hexadactyly of hands and feet, pancreatic cystic dysplasia, renal dysplasia/ absence, micropenis and ambiguous genitalia, imperforate anus. Am J Med Genet 1989;34:401-5. 124
  116. Nivelon A, Nivelon JL, Mabille JP, et al. New autosomal recessive chondrodysplasia-pseudohermaphroditism syn- drome. Clin Dysmorphol 1992;1:221-7. 125
  117. Clark RM, Fey MB, Jensen RG, Hill DW. Desmosterol in human milk. Lipids 1983;18:264-6. 126
  118. Bourre JM, Clement M, Gerard D, Chaudiere J. Alterations of cholesterol synthesis precursors (7- dehydrocholesterol, 7-dehydrodesmosterol, desmosterol) in dysmyelinating neurological mutant mouse (quaking, shiverer and trembler) in the PNS and the CNS. Biochim Biophys Acta 1989;1004:387-90. 127
  119. Lin DS, Connor WE, Wolf DP, Neuringer M, Hachey DL. Unique lipids of primate spermatozoa: desmosterol and docosahexaenoic acid. J Lipid Res 1993;34:491-9. 128
  120. Liscum L, Klansek JJ. Niemann-Pick disease type C. Curr Opin Lipidol 1998;9:131-5. 129
  121. Carr BR, Simpson ER. Cholesterol synthesis in human fetal tissues. J Clin Endocrinol Metab 1982;55:447-52. 130
  122. Bellknap WM, Dietschy JM. Sterol synthesis and low- density lipoprotein clearance in vivo in the pregnant rat, placenta, and fetus. J Clin Invest 1988;82:2077-84. 131
  123. Tint GS, Seller M, Hughes-Benzie R, et al. Markedly increased tissue concentrations of 7-dehydrocholesterol combined with low levels of cholesterol are characteristic of the Smith-Lemli-Opitz syndrome. J Lipid Res 1995;36:89- 95. 132
  124. Pardridge WM, Mietus LJ. Palmitate and cholesterol transport through the blood-brain barrier. J Neurochem 1980;34:463-6. 133
  125. Morell P, Jurevics H. Origin of cholesterol in myelin. Neu- rochem Res 1996;21:463-70. 134
  126. Farese RV Jr, Ruland SL, Flynn LM, Stokowski RP, Young SG. Knockout of the mouse apolipoprotein B gene results in embryonic lethality in homozygotes and protection against diet-induced hypercholesterolemia in heterozy- gotes. Proc Natl Acad Sci USA 1995;92:1774-8. 135
  127. Willnow TE, Hilpert J, Armstrong SA, et al. Defective forebrain development in mice lacking gp330/megalin. Proc Natl Acad Sci USA 1996;93:8460-4. 136
  128. Roessler E, Belloni E, Gaudenz K, et al. Mutations in the human Sonic Hedgehog gene cause holoprosencephaly. Nat Genet 1996;14:357-60. 137
  129. Porter JA, Young KE, Beachy PA. Cholesterol modification of Hedgehog signaling proteins in animal development. Science 1996;274:255-9. 138
  130. Chiang C, Litingtung Y, Lee E, et al. Cyclopia and defec- tive axial patterning in mice lacking Sonic hedgehog gene function. Nature 1996;383:407-13. 139
  131. Roux C, Aubry MM. Action tératogene chez le rat d'un inhibiteur de la synthese du cholesterol, le AY 9944. C R Soc Biol 1966;160:1353-7. 140
  132. Barbu V, Roux C, Lambert D, et al. Cholesterol prevents the teratogenic action of AY 9944: importance of the tim- ing of cholesterol supplementation to rats. J Nutr 1988;118:774-9. 141
  133. Porter JA, von Kessler DP, Ekker SC, Young KE, Moses K, Beachy PA. The product of hedgehog autoproteolytic cleav- age active in local and long-range signalling. Nature 1995;374:363-6. 142
  134. Bitgood MJ, Shen L, McMahon AP. Sertoli cell signaling by Desert hedgehog regulates the male germline. Curr Biol 1996;6:298-304. 143
  135. Iwasaki M, Le AX, Helms JA. Expression of indian hedge- hog, bone morphogenetic protein 6 and gli during skeletal morphogenesis. Mech Dev 1997;69:197-202. 144
  136. Cooper MK, Porter JA, Young KA, Beachy PA. Plant- derived and synthetic teratogens inhibit the ability of target tissues to respond to Sonic hedgehog signaling. Science 1998;280:1603-7. 145
  137. Stone DM, Hynes M, Armanini M, et al. The tumour- suppressor gene patched encodes a candidate receptor for Sonic hedgehog. Nature 1996;384:129-34. 146
  138. Silve S, Dupuy PH, Ferrara P, Loison G. Human lamin B receptor exhibits sterol C14-reductase activity in Saccharo- myces cerevisiae. Biochim Biophys Acta 1998;1392:233-44. 147
  139. DeHart DB, Lanoue L, Tint GS, Sulik KK. A rodent model of Smith-Lemli-Opitz syndrome; BM 15.766 induced teratogenesis. Am J Med Genet 1996;68:328-37. 148
  140. Lanoue L, Dehart DB, Hinsdale ME, Maeda N, Tint GS, Sulik KK. Limb, genital, CNS, and facial malformations result from gene/environment-induced cholesterol deficiency: further evidence for a link to sonic hedgehog. Am J Med Genet 1997;73:24-31. 149
  141. Stamellos KD, Shackelford JE, Tanaka RD, Krisans SK. Mevalonate kinase is localized in rat liver peroxisomes. J Biol Chem 1992;267:5560-8. 150
  142. Biardi L, Krisans SK. Compartmentalization of cholesterol biosynthesis. Conversion of mevalonate to farnesyl diphos- phate occurs in the peroxisomes. J Biol Chem 1996;271: 1784-8. 151 Krisans SK. The role of peroxisomes in cholesterol metabolism. Am J Resp Cell Mol Biol 1992;7:358-64. 152
  143. Tint GS, Salen G, Batta AK, et al. Correlation of severity and outcome with plasma sterol levels in variants of the Smith-Lemli-Opitz syndrome. J Pediatr 1995;127:82-7. 153
  144. Abuelo DN, Tint GS, Kelley R, Batta AK, Shefer S, Salen G. Prenatal detection of the cholesterol biosynthetic defect in the Smith-Lemli-Opitz syndrome by the analysis of amniotic fluid sterols. Am J Med Genet 1995;56:281-5. 155
  145. Kelley RI. RSH/Smith-Lemli-Opitz syndrome: mutations and metabolic morphogenesis. Am J Hum Genet 1998;63: 322-6. 156
  146. Roux C, Horvath C, Dupuis R. Teratogenic action and embryo lethality of AY 9944R. Prevention by a hypercholesterolemia-provoking diet. Teratology 1979;19: 35-8. 157
  147. Roux C, Dupuis R, Horvath C, Giroud A. Interpretation of isolated agenesis of the pituitary. Teratology 1979;19:39-43. 158
  148. Kolf-Clauw M, Chevy F, Siliart B, Wolf C, Mulliez N, Roux C. Cholesterol biosynthesis inhibited by BM15.766 induces holoprosencephaly in the rat. Teratology 1997;56: 188-200. 159
  149. Lecain E, Chenivesse X, Spagnoli R, Pompon D. Cloning by metabolic interference in yeast and enzymatic charac- terization of Arabidopsis thaliana sterol delta 7-reductase. J Biol Chem 1996;271:10866-73. 160
  150. Alley TL, Scherer SW, Huizenga JJ, Tsui LC, Wallace MR. Physical mapping of the chromosome 7 breakpoint region in an SLOS patient with t(7;20) (q32.1;q13.2). Am J Med Genet 1997;68:279-81. 161
  151. Moebius FF, Striessnig J, Glossmann H. The mysteries of sigma receptors: new family members reveal a role in chol- esterol synthesis. Trends Pharmacol Sci 1997;18:67-70. 162
  152. Fitzky BU, Witsch-Baumgartner M, Erdel M, et al. Muta- tions in the delta7-sterol reductase gene in patients with the Smith-Lemli-Opitz syndrome. Proc Natl Acad Sci USA 1998;95:8181-6. 163
  153. Witsch-Baumgartner M, Ogorelkova M, Kraft HG, et al. Mutational spectrum and genotype-phenotype correlation in 84 patients with Smith-Lemli-Opitz syndrome. Am J Hum Genet 2000;66:402-412. 164
  154. Honda M, Tint GS, Honda A, et al. Measurement of 3 beta-hydroxysteroid delta 7-reductase activity in cultured skin fibroblasts utilizing ergosterol as a substrate: a new method for the diagnosis of the Smith-Lemli-Opitz syndrome. J Lipid Res 1996;37:2433-8. 165
  155. Honda A, Tint GS, Salen G, et al. Sterol concentrations in cultured Smith-Lemli-Opitz syndrome skin fibroblasts: diagnosis of a biochemically atypical case of the syndrome. Am J Med Genet 1997;68:282-7. 166
  156. Oostra RJ, Baljet B, Schutgens RBH, Hennekam RCM. Smith-Lemli-Opitz syndrome diagnosed in a 130-year-old anatomical specimen. Am J Med Genet 1997;68:257-9. 167
  157. Cruz MLA, Wong WW, Mimouni F, et al. EVects of infant nutrition on cholesterol synthesis rates. Pediatr Res 1994;35:135-40. 168
  158. Jones JH. Regulation of cholesterol biosynthesis by diet in humans. Am J Clin Nutr 1997;66:438-46. 169
  159. Elias ER, Irons MB, Hurley AD, Tint GS, Salen G. Clini- cal eVects of cholesterol supplementation in six patients with the Smith-Lemli-Opitz syndrome (SLOS). Am J Med Genet 1997;68:305-10. 170
  160. Irons M, Elias ER, Abuelo D, et al. Treatment of Smith-Lemli-Opitz syndrome: results of a multicenter trial. Am J Med Genet 1997;68:311-14. 171
  161. Ullrich K, Koch HG, Meschede D, Flotmann U, Seedorf U. Smith-Lemli-Opitz syndrome: treatment with choles- terol and bile acids. Neuropediatrics 1996;27:111-12. 172
  162. Xu G, Salen G, Shefer S, et al. Treatment of the cholesterol biosynthetic defect in Smith-Lemli-Opitz syndrome repro- duced in rats by BM 15.766. Gastroenterology 1995;109: 1301-7.

Cited by

Sorted by citations

Authors
Kelley, R. I., & Hennekam, R. C. M.
Affiliations
Kennedy Krieger Institute (US)
Corresponding author
Kelley, Richard I
Venue
Journal of Medical Genetics
Publisher
BMJ
Published
2000-05-01
Volume
37
Issue
5
Pages
321-335
ISSN
  • 0022-2593 (ISSN-L)
  • 1468-6244
OpenAlex
W2143076431
Cited by
480
References
6
Citations by year
2026: 4 · 2025: 10 · 2024: 14 · 2023: 13 · 2022: 12 · 2021: 13 · 2020: 10 · 2019: 17 · 2018: 10 · 2017: 17 · 2016: 22 · 2015: 11 · 2014: 23 · 2013: 24 · 2012: 27
FWCI
4.97
Type
journal article
Language
en
Open access
Locations
  • Journal of Medical Genetics (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • UvA-DARE (University of Amsterdam) (submittedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
  • Pure Amsterdam UMC (submittedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
  • Health Sciences › Medicine › Surgery › Cholesterol and Lipid Metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and rare skin diseases.
Keywords
Smith-Lemli-Opitz syndrome, cholesterol metabolism, multiple congenital anomalies, embryonic development, Hedgehog signaling, homeobox genes, steroidogenesis, behavioural abnormalities
MeSH terms
Cholesterol, Humans, Oxidoreductases, Smith-Lemli-Opitz Syndrome, Oxidoreductases Acting on CH-CH Group Donors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review